Press Digest: Canada - Nov 22

Zymeworks

22/11/2024 13:26

Nov 22 (Reuters) - The following are the top stories
from a selected Canadian newspaper. Reuters has not verified
these stories and does not vouch for their accuracy.
    
    
    THE GLOBE AND MAIL
    ** The federal government unveiled its multi billion-dollar
plan to alleviate pocketbook pressures for households, dropping
the GST on a wide range of products for a two-month period and
sending most working Canadians a $250 cheque in April.
    
    ** Jazz Pharmaceuticals  JAZZ.O , which licensed Zymeworks'
 ZYME.O  lead cancer drug zanidatamab in 2022 for North America,
Europe and Japan, said the U.S. FDA had approved use of the
tumour-fighting antibody to treat adults with a form of
biliary-tract cancer.

    **A shareholder advocacy group is calling on
Toronto-Dominion Bank  TD.TO  to launch an independent review of
its board of directors after an investigation by U.S. regulators
and law enforcement found it guilty of conspiracy to commit
money laundering.

 (Compiled by Bengaluru newsroom)
 ((globalnewsmonitoring@thomsonreuters.com))